Despite a highly profitable business model and a strong position in the medical aesthetics industry, INMD stock is down -33% over the last 12 months. Macroeconomic pressures, political risks in InMode ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback